Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience

BACKGROUND: The aim of the study was to evaluate the achievement of ‘no evidence of disease activity’ (NEDA) over a 12-month period in a large multicenter population with relapsing remitting multiple sclerosis (RRMS) treated with delayed-release dimethyl fumarate (DMF) and teriflunomide (TRF) using...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ther Adv Neurol Disord
Main Authors: D’Amico, Emanuele, Zanghì, Aurora, Callari, Graziella, Borriello, Giovanna, Gallo, Antonio, Graziano, Giusi, Valentino, Paola, Buccafusca, Maria, Cottone, Salvatore, Salemi, Giuseppe, Ragonese, Paolo, Bossio, Roberto Bruno, Docimo, Renato, Grimaldi, Luigi Maria Edoardo, Pozzilli, Carlo, Tedeschi, Gioacchino, Zappia, Mario, Patti, Francesco
Formato: Artigo
Idioma:Inglês
Publicado: SAGE Publications 2018
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6131312/
https://ncbi.nlm.nih.gov/pubmed/30210582
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286418796404
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares